3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Sarcoma, Synovial
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
PRETEXT I Hepatoblastoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Localized Extraskeletal Ewing Sarcoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Ganglioneuroblastoma
1
Fibrosarcoma
1
Dermatofibrosarcoma
1
Central Nervous System Neoplasms
1
Interventions
Cyclophosphamide
13
Doxorubicin
9
Trastuzumab
8
Taxes
7
Paclitaxel
7
Docetaxel
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
Radiotherapy
4
Epirubicin
4
pertuzumab
3
pembrolizumab
3
Melphalan
3
130-nm albumin-bound paclitaxel
3
eribulin
2
Thiotepa
2
Tamoxifen
2
Peripheral Blood Stem Cell Transplantation
2
Lapatinib
2
Fluorouracil
2
Filgrastim
2
Bevacizumab
2
2C4 antibody
2
trastuzumab biosimilar HLX02
1
talimogene laherparepvec
1
sargramostim
1
ruxolitinib
1
romidepsin
1
pegfilgrastim
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Inflammatory Breast Neoplasms
×
Razoxane
×
Clear all
No trials found.